Home » Hagar’s GWave Glucose Monitor Designated an FDA Breakthrough Device
Hagar’s GWave Glucose Monitor Designated an FDA Breakthrough Device
The FDA has designated Hagar’s GWave noninvasive continuous glucose monitoring system a breakthrough device.
The GWave device is one-third the size of a smartphone and involves less radiofrequency exposure for users than a smartphone, the Israel-based company said.
The device uses radiofrequency waves to measure glucose levels in the blood without the need for a blood sample.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May